This site is intended for healthcare professionals only
LoginRegister
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon concludes Rs 4500 crore equity fundraise through QIP
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation
Granules Indias US Arm Gets 4 USFDA ObservationsGranules India Bonthapally API facility gets 1 USFDA observation
Counterfeit version of Sun Pharma Cholesterol lowering drugs worth Rs 3 lakhs seized in HyderabadCounterfeit version of Sun Pharma Cholesterol lowering drugs worth Rs 3 lakhs seized in Hyderabad
USFDA Reappoints Vinay Prasad to Top Medical and Scientific RoleVinay Prasad named Chief Medical and Science Officer at USFDA: Report
Sanofi DupixentSanofi Dupixent gets USFDA nod for bullous pemphigoid treatment in adults
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA inspection: Natco Pharma gets 7 observations for Kothur Pharma Division
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRelCDSCO Panel Rejects Phase II Data for Reliance's RelCoVax COVID-19 Booster Over Immunogenicity Gap
Pill form of Wegovy gets USFDA approval for weight lossNovo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab Study
ED Pulls Up 5 Pharma Firms in Tramadol-Alprazolam Black Market ProbeED Pulls Up 5 Pharma Firms in Tramadol-Alprazolam Black Market Probe
Indian Pharma market sees 6.9% Growth in May: ReportIndian Pharma market sees 6.9% growth in May: Report
Morepen LabsMorepen Labs incorporates wholly owned subsidiary in Dubai
X